Core Viewpoint - The impressive performance of the company is primarily driven by investment gains rather than a recovery in its main business operations [2][3]. Group 1: Financial Performance - The company expects a net profit attributable to shareholders of between 750 million to 950 million yuan for 2025, a significant turnaround from a loss of 71.96 million yuan in the previous year [2]. - The main driver of this turnaround is a substantial increase in non-recurring gains, particularly from the fair value changes of its investment in Hunan Mingming Henbang Commercial Chain Co., Ltd. [2]. - The company reported a projected net loss of 50 million to 80 million yuan when excluding non-recurring items, indicating ongoing pressure in its core red date and health food business [3]. Group 2: Business Operations - The company, known as the "first stock of red dates," has faced continuous pressure in its main business due to changes in consumer demand and intensified industry competition [3]. - Since divesting from Baicaowei and refocusing on the red date business, the company's revenue has remained stagnant between 1 billion to 2 billion yuan, failing to break through this range [3]. - The company has accumulated losses exceeding 300 million yuan over the past three years, with net profits attributable to shareholders reported as -189 million yuan, -52 million yuan, and -72 million yuan for 2022 to 2024 [3]. Group 3: Future Outlook - The company has set performance targets in its employee stock ownership plan, aiming for a net profit of no less than 20 million yuan in 2026 and 50 million yuan in 2027, excluding stock payment expenses and investment gains from Mingming Henbang [4].